24 results
6-K
EX-99.1
CNTB
Connect Biopharma Holdings Ltd
21 Nov 23
Exclusive License and Collaboration Agreement
6:13am
for sale or contract to sell) or otherwise commercially Exploit (including to conduct pricing and reimbursement activities) a pharmaceutical … and maintain the Regulatory Approvals and applicable pricing or reimbursement approvals.
1.20. “Field” shall mean all human diseases, symptoms
20-F
2021 FY
EX-4.10
CNTB
Connect Biopharma Holdings Ltd
31 Mar 22
Annual report (foreign)
4:33pm
payable under this Addendum shall be subject to an “additional tax” as defined in Section 409A(a)(1)(B) of the Code.
(d)Any reimbursement of expenses … benefits payable during any taxable year of yours shall not affect the amount eligible for reimbursement or in-kind benefits payable in any other
20-F
vlgwykg9cuf57j4j
31 Mar 22
Annual report (foreign)
4:33pm
20-F
EX-4.13
je50z0ykq1v
31 Mar 22
Annual report (foreign)
4:33pm
20-F
EX-4.11
qp53f xv0o
31 Mar 22
Annual report (foreign)
4:33pm
S-8
EX-4.3
wl7kbhm lc
19 Mar 21
Registration of securities for employees
5:13pm
424B4
q5vc1k0 ucr
19 Mar 21
Prospectus supplement with pricing info
4:49pm
F-1/A
8phy7ixwl zafjzur
18 Mar 21
Registration statement (foreign) (amended)
6:15am
F-1/A
xpy4f
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
F-1/A
EX-1.1
jvskc
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
F-1/A
EX-4.2
vj0jp1xtdsixqzln0obc
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
F-6
EX-4
qmxfebl 7r3f9
12 Mar 21
Registration for ADRs (foreign)
4:05pm
F-1
u8zupxyyhj11ksu
26 Feb 21
Registration statement (foreign)
4:56pm
F-1
EX-10.8
p2qgf3sa
26 Feb 21
Registration statement (foreign)
4:56pm
F-1
EX-10.5
qe6ap8
26 Feb 21
Registration statement (foreign)
4:56pm
F-1
EX-10.15
5falh
26 Feb 21
Registration statement (foreign)
4:56pm
F-1
EX-10.11
rtgrjse
26 Feb 21
Registration statement (foreign)
4:56pm